financetom
Business
financetom
/
Business
/
Twitter comes up with 'poison pill' strategy to thwart Elon Musk takeover bid
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Twitter comes up with 'poison pill' strategy to thwart Elon Musk takeover bid
Apr 16, 2022 2:19 AM

Twitter Inc. on Friday came up with a ‘poison pill’ strategy to thwart $43 billion cash takeover bid by billionaire entrepreneur Elon Musk.

Share Market Live

NSE

As per the ‘poison pill’ strategy the rights will become exercisable if anyone acquires ownership of 15% or more of Twitter’s outstanding common stock in a transaction not approved by the Board.

The rights plan will expire on April 14, 2023, Twitter said.

Musk made the bid on April 13 in a letter to the board of Twitter and his $54.20 per share offer price was disclosed in a regulatory filing. It represents a 38 percent premium to the April 1 close of Twitter. April 1 was the last trading day before the Musk's over 9 percent stake in the firm was made public

After his TED talk on Thursday, Musk hinted at the possibility of a hostile bid in which he would bypass Twitter’s board and put the offer directly to its shareholders, tweeting: “It would be utterly indefensible not to put this offer to a shareholder vote.”

Just few days back Musk rejected a seat on the board of Twitter.

(Edited by : Sudarsanan Mani)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Capricor Therapeutics, Nippon Shinyaku Sign Binding Term Sheet for Commercialization of Duchenne Muscular Dystrophy Treatment in Europe
Capricor Therapeutics, Nippon Shinyaku Sign Binding Term Sheet for Commercialization of Duchenne Muscular Dystrophy Treatment in Europe
Sep 17, 2024
10:31 AM EDT, 09/17/2024 (MT Newswires) -- Capricor Therapeutics ( CAPR ) said Tuesday it signed a binding term sheet with Japanese pharmaceutical firm Nippon Shinyaku to commercialize and distribute Capricor's Duchenne muscular dystrophy treatment deramiocel in Europe. Capricor said the potential deal that the term sheet covers is similar to the existing commercialization and distribution agreements with Nippon Shinyaku...
INmune Bio Says AD02 Trial for Alzheimer's Disease Reveals Strong Performance of EMACC Cognitive Measure
INmune Bio Says AD02 Trial for Alzheimer's Disease Reveals Strong Performance of EMACC Cognitive Measure
Sep 17, 2024
10:19 AM EDT, 09/17/2024 (MT Newswires) -- INmune Bio ( INMB ) said Tuesday that additional analysis from its AD02 phase 2 trial for Alzheimer's disease showed exceptional performance of the Early AD/MCI Alzheimer's Cognitive Composite, or EMACC, measure. The analysis revealed a highly significant correlation between baseline scores on EMACC and the Clinical Dementia Rating-Sum of Boxes, or CDR-SB,...
Intel Updates Viewed in 'Positive Light' But Not Sufficient to Overcome Challenges, Truist Says
Intel Updates Viewed in 'Positive Light' But Not Sufficient to Overcome Challenges, Truist Says
Sep 17, 2024
10:20 AM EDT, 09/17/2024 (MT Newswires) -- Intel's ( INTC ) recent business update announcements are viewed in a positive light but are not sufficient to overcome issues the company is facing, Truist Securities said in a note Tuesday. The highlights include Intel Foundry operating as an independent unit; the company receiving up to $3 billion in US government chip...
Uber to roll out 'verified' rider badge, trip recording features in US
Uber to roll out 'verified' rider badge, trip recording features in US
Sep 17, 2024
Sept 17 (Reuters) - Uber ( UBER ) is rolling out features that would allow its drivers to see verified badges on customer profiles and record trips on their smartphones instead of a dashcam, the ride-hailing firm said on Tuesday. This is expected to improve safety of drivers and comes against the backdrop of a 2021-22 safety report by Uber...
Copyright 2023-2025 - www.financetom.com All Rights Reserved